Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ozer

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Cancer Investigation|January 1, 1990
Basic and clinical utility of gamma interferonH Ozer
Progress in Clinical and Biological Research|January 1, 1990
Mechanisms of action of interferonH Ozer
Biotechnology Therapeutics|January 1, 1989
Clinical and biological activities of interferon and hematological malignanciesH Ozer
Current Opinion in Oncology|December 1, 1989
Cytokines in oncologyH Ozer
Current Opinion in Hematology|January 1, 1996
American Society of Clinical Oncology guidelines for the use of hematopoietic colony-stimulating factorsH Ozer
Seminars in Hematology|June 1, 2000
Clinical issues and treatment advances in thrombocytopenia: introductionH Ozer
Seminars in Oncology|October 1, 1988
Biotherapy of chronic myelogenous leukemia with interferonH Ozer
The Virtual Mentor : VM|January 29, 2013
Getting personal: the promises and potential pitfalls of personalized medicineByram H Ozer
Acta Neurochirurgica|November 7, 1999
Myelomeningocele, dermal sinus tract, split cord malformation associated with extradural teratoma in a 30-month-Old girlH Ozer, N Yüceer
Lancet (London, England)|October 6, 1979
Are K cells low-affinity E-rosetting cells?A Early, H Ozer
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Cancer Investigation|January 1, 1990
Basic and clinical utility of gamma interferonH Ozer
Progress in Clinical and Biological Research|January 1, 1990
Mechanisms of action of interferonH Ozer
Biotechnology Therapeutics|January 1, 1989
Clinical and biological activities of interferon and hematological malignanciesH Ozer
Current Opinion in Oncology|December 1, 1989
Cytokines in oncologyH Ozer
Current Opinion in Hematology|January 1, 1996
American Society of Clinical Oncology guidelines for the use of hematopoietic colony-stimulating factorsH Ozer
Seminars in Hematology|June 1, 2000
Clinical issues and treatment advances in thrombocytopenia: introductionH Ozer
Seminars in Oncology|October 1, 1988
Biotherapy of chronic myelogenous leukemia with interferonH Ozer
The Virtual Mentor : VM|January 29, 2013
Getting personal: the promises and potential pitfalls of personalized medicineByram H Ozer
Acta Neurochirurgica|November 7, 1999
Myelomeningocele, dermal sinus tract, split cord malformation associated with extradural teratoma in a 30-month-Old girlH Ozer, N Yüceer
Lancet (London, England)|October 6, 1979
Are K cells low-affinity E-rosetting cells?A Early, H Ozer
Pageof 22